Related Experiment Video
Updated: Jun 23, 2025

08:36
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
3.7K
Using Medical Device Standards for Design and Risk Management of Immersive Virtual Reality for At-Home Therapy and
1Playhab R&D, Cognivive, Inc., Davis, CA, United States.
JMIR Biomedical Engineering
|June 22, 2024
Summary
This paper outlines a risk management process for immersive virtual reality (VR) medical devices used for remote patient monitoring. It ensures the safe and effective development of VR therapies for at-home rehabilitation.
Area of Science:
- Medical device development
- Virtual Reality (VR) therapy
- Human-Computer Interaction
Background:
- Numerous virtual reality (VR) systems are approved as therapeutic medical devices for both clinic and home use, enabling remote patient monitoring.
- While most current VR systems are non-immersive, the rise of affordable head-mounted displays (HMDs) fuels interest in immersive VR therapies.
- Immersive VR, particularly HMD-based systems for at-home use, introduces unique safety risks that necessitate a structured risk management approach.
Purpose of the Study:
- To demonstrate a comprehensive risk management process for a generic immersive VR system intended for remote patient monitoring during at-home therapy.
- To identify applicable regulations, standards, and guidance documents for therapeutic VR medical device development.
- To establish generic requirements for immersive VR systems for home use and remote monitoring, considering both patient and clinician perspectives.
Main Methods:
- Review of relevant regulations, standards, and guidance for therapeutic VR medical device design.
- Predicate analysis and user story generation to define system requirements for patients and clinicians.
- Application of Failure Modes and Effects Analysis (FMEA), adapted for medical device risk management, to identify potential risks.
- Proposal of risk control measures based on the FMEA findings.
Main Results:
- Identification of specific risks associated with immersive VR systems for remote, at-home patient monitoring.
- Development of a generic set of user requirements for patients and clinicians.
- Proposal of a systematic risk management framework, including risk control measures.
- Demonstration of how FMEA can be applied to immersive VR medical device risk analysis.
Conclusions:
- Many VR therapeutic applications will be regulated as medical devices, requiring adherence to design and risk management standards.
- Early integration of risk management principles and relevant standards can accelerate the development of safe and effective immersive VR therapies.
- A structured risk management process is crucial for mitigating the unique challenges posed by immersive VR for remote patient monitoring.

